Novel γ-aminobutyric acid (GABA) analogues -, having a bicyclo[3.1.0]hexene, [4.1.0]heptane, or [4.1.0]heptene backbone, respectively, were designed from the bioactive form analysis of the previous inhibitor with a bicyclo[3.1.0]hexane backbone. Compounds - and were synthesized from a common 1,7-diene intermediate using ring-closing metathesis (RCM) to construct the key bicyclo backbones. Compounds - strongly inhibit betaine/GABA transporter 1 (BGT1) uptake, but compound stands out with its selective low micromolar potency.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.orglett.2c01346 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!